Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Achieve Life Sciences, Inc. (ACHV) had Debt to Equity Ratio of 0.30 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-14.44M |
|
-- |
|
-- |
|
$14.69M |
|
$-14.69M |
|
$0.25M |
|
$-14.44M |
|
$-14.44M |
|
$-14.44M |
|
$-14.44M |
|
$-14.44M |
|
$-14.44M |
|
$-14.69M |
|
$-14.62M |
|
51.02M |
|
51.02M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$50.05M |
|
-- |
|
$1.99M |
|
$52.04M |
|
$9.73M |
|
$8.70M |
|
$8.70M |
|
$18.43M |
|
$33.62M |
|
$31.77M |
|
$33.62M |
|
52.81M |
|
| Cash Flow Statement Financials | |
$-31.49M |
|
$5.40M |
|
$45.26M |
|
$12.77M |
|
$31.95M |
|
$19.18M |
|
$7.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.14 |
|
-- |
|
-- |
|
0.21 |
|
|
Debt to Equity Ratio |
0.30 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-31.49M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-42.96% |
|
-45.45% |
|
-27.75% |
|
-34.13% |
|
$0.64 |
|
$-0.62 |
|
$-0.62 |
|